Key result
Minimally invasive direct coronary artery bypass (MIDCAB) offers shorter hospital stays and cost effectiveness, though long-term efficacy and anastomosis quality require further validation.
Why the study?
Is minimally invasive direct coronary artery bypass (MIDCAB) without cardiopulmonary bypass as effective and safe as conventional CABG?
Is minimally invasive direct coronary artery bypass (MIDCAB) without cardiopulmonary bypass as effective and safe as conventional CABG?
MIDCAB offers short-term benefits like shorter hospital stays, but requires further evidence of long-term safety and efficacy compared to conventional CABG before widespread adoption.
MIDCAB may shorten stays and cut costs in selected patients; leaves open long-term efficacy versus conventional CABG.
Minimally invasive coronary artery bypass grafting (CABG) aims to avoid cardiopulmonary bypass and take maximum advantage of a smaller incision. Minimally invasive direct coronary artery bypass (MIDCAB) surgery is performed on selected arteries of the beating heart under direct vision through a choice of small incisions. Short-term results show good patency rates and a dramatic impact in terms of shorter hospital stays and cost effectiveness. The procedure is also being used increasingly in Japan. However, valid concerns have been raised about the quality of the anastomosis fashioned on a beating heart with pharmacologic bradycardia, and the long-term result of this technique is still questionable. The combined use of circulatory assist devices and mechanical stabilizing devices will be expected to expand access to coronary arteries by allowing for decompression of the left ventricle, permitting retraction and rotation of the heart, and hopefully further improvement of the results. Less invasive coronary surgery should be proven to be as effective and safe as conventional CABG before widespread adoption.
No takes yet. Share an insight, caveat, or question.
Shiono et al. (1998) conducted a review in Coronary artery disease. Minimally invasive direct coronary artery bypass (MIDCAB) vs. Conventional CABG was evaluated. Minimally invasive direct coronary artery bypass (MIDCAB) offers shorter hospital stays and cost effectiveness, though long-term efficacy and anastomosis quality require further validation.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: